Storage and handling
Other Information: Store out of direct sunlight between 15 degrees C and 30 degrees C (59 degrees F - 86 degrees F)
Other Information: Store out of direct sunlight between 15 degrees C and 30 degrees C (59 degrees F - 86 degrees F)
Active Ingredients:
Purified water USP 98.6%
Uses: For irrigating the eyes to remove loose foreign material, air pollutants, chlorinated water and for flushing the skin.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Other Information:
Store out of direct sunlight between 15 degrees C and 30 degrees C (59 degrees F - 86 degrees F)
Inactive Ingredients:
Potassium phosphate monobasic, sodium chloride USP, sodium hydroxide.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1489093 | Salinaax 98.6 % Ophthalmic Irrigation Solution | PSN | 5 |
| 1053173 | water 98.6 % Ophthalmic Irrigation Solution | PSN | 5 |
| 1489093 | water 986 MG/ML Ophthalmic Irrigation Solution [Salinaax] | SBD | 5 |
| 1053173 | water 986 MG/ML Ophthalmic Irrigation Solution | SCD | 5 |
| 1489093 | Salinaax 98.6 % Ophthalmic Irrigation Solution | SY | 5 |
| 1489093 | Salinaax 986 MG/ML Ophthalmic Irrigation Solution | SY | 5 |
| 1053173 | water 98.577 % Ophthalmic Irrigation Solution | SY | 5 |
| 1053173 | water 98.6 % Ophthalmic Irrigation Solution | SY | 5 |
| 1053173 | water 98.6 ML per 100 ML Ophthalmic Irrigation Solution | SY | 5 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4b7700e3-6e0e-45e5-9d22-6f754d61386e | Product name | 2 | 20250304 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68276-005-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c38f-8e05-e053-dbdaa90a074a | e5ed271a-46e7-479a-b603-3e5c6f38815f |
| 68276-005-02 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c38f-8e05-e053-dbdaa90a074a | e5ed271a-46e7-479a-b603-3e5c6f38815f |
| 68276-005-03 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c38f-8e05-e053-dbdaa90a074a | e5ed271a-46e7-479a-b603-3e5c6f38815f |
| 68276-005-04 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c38f-8e05-e053-dbdaa90a074a | e5ed271a-46e7-479a-b603-3e5c6f38815f |
| 68276-005-05 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c38f-8e05-e053-dbdaa90a074a | e5ed271a-46e7-479a-b603-3e5c6f38815f |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68276-005-01 | SalinaaxEye Wash and Skin Flush | 148 mL in 1 BOTTLE | RINSE | 148 | 5 | |
| 68276-005-02 | SalinaaxEye Wash and Skin Flush | 236 mL in 1 BOTTLE | RINSE | 236 | 5 | |
| 68276-005-03 | SalinaaxEye Wash and Skin Flush | 472 mL in 1 BOTTLE | RINSE | 472 | 5 | |
| 68276-005-04 | SalinaaxEye Wash and Skin Flush | 944 mL in 1 BOTTLE | RINSE | 944 | 5 | |
| 68276-005-05 | SalinaaxEye Wash and Skin Flush | 15 mL in 1 BOTTLE | RINSE | 15 | 5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Water | ACTIVE INGREDIENT | 059QF0KO0R | 5 | |
| Water | ACTIVE MOIETY | 059QF0KO0R | 5 | |
| Potassium phosphate, monobasic | INACTIVE INGREDIENT | 4J9FJ0HL51 | 5 | |
| Sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | 5 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68276-005 | 68276-005-01, 68276-005-02, 68276-005-03, 68276-005-04, 68276-005-05 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Water | 059QF0KO0R | ACTIB |
| Potassium phosphate, monobasic | 4J9FJ0HL51 | IACT |
| Sodium chloride | 451W47IQ8X | IACT |
| Sodium hydroxide | 55X04QC32I | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SYSTEM / IONTOPHORESIS | 3.1 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERINEURAL | 648 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | LOTION / TOPICAL | 0.3 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / PARENTERAL | 210 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / AURICULAR (OTIC) | ADJ PH | ||
| Potassium phosphate, monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SOLUTION / AURICULAR (OTIC) | 0.2 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 0.86 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAMUSCULAR | 17 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / PARENTERAL | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INFILTRATION | ADJ PH | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVENOUS | 0.9 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL | 226 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | DROPS / ORAL | NA | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SOLUTION / ORAL | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / PARENTERAL | ADJ PH | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2922 mg | ||
| Potassium phosphate, monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SYRUP / ORAL | 19 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRA-ARTICULAR | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRABURSAL | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | LOTION / TOPICAL | 21 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRA-ARTERIAL | 278 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CONCENTRATE / ORAL | 10 mg/5ml | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / AURICULAR (OTIC) | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / RETROBULBAR | ADJ PH | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SPRAY / NASAL | ADJ PH | ||
| Potassium phosphate, monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION, SOLUTION / INTRAVESICAL | 29.2 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRATHECAL | 1.35 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / TOPICAL | 39 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / SUBCUTANEOUS | 90 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION/ DROPS / OPHTHALMIC | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | ADJ PH | ||
| Potassium phosphate, monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION / SUBCUTANEOUS | 8 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INFILTRATION | 648 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | EMULSION / OPHTHALMIC | 0.02 %w/v | ||
| Potassium phosphate, monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SPRAY / NASAL | 3 mg | ||
| Potassium phosphate, monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | TABLET / ORAL | 25 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRADISCAL | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | FILM / BUCCAL | 0.09 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVENOUS | 456 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRATHECAL | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRADERMAL | ADJ PH | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / URETERAL | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRACAVITARY | ADJ PH | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / SUBCUTANEOUS | 1 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVASCULAR | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | ADJ PH | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRATUMOR | ADJ PH | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / RECTAL | NA | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRATHECAL | ADJ PH |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 80984d7b-efbd-452b-aea4-8f1d83d5ee25 | e5ed271a-46e7-479a-b603-3e5c6f38815f | 2011-03-11 | Warnings | 80984d7b-efbd-452b-aea4-8f1d83d5ee25 e5ed271a-46e7-479a-b603-3e5c6f38815f |
Adverse event summaries are temporarily unavailable. Other product information remains available.